Short influenza postexposure prophylaxis (PEP) showed high efficacy in adults, but studies
in children are lacking. This randomized open-label pilot trial aimed to verify noninferiority of …

Background In a previous retrospective observational study, a 3-day regimen of oseltamivir
as post-exposure prophylaxis (PEP) for preventing transmission of influenza in wards was …

Background The efficacy and optimal duration of postexposure influenza prophylaxis with
oseltamivir are undetermined in hospital settings, where immediate separation from index …

Please cite this paper as: Reisinger et al. Safety and tolerability of a 6‐week course of
oseltamivir prophylaxis for seasonal influenza in children. Influenza and Other Respiratory …

Purpose Infants and young children are at elevated risk of influenza‐associated
complications, but information on the safety of antiviral therapies is limited in this age group …

Objective To describe the effectiveness of containment of novel influenza A (H1N1) infection
at a summer camp. Design Targeted use of oseltamivir phosphate by individuals in close …

Background: Postexposure prophylaxis (PEP) using neuraminidase inhibitors against
exposure to influenza virus has been well studied in household settings but not in …

Importance Oseltamivir is recommended for all children hospitalized with influenza, despite
limited evidence supporting its use in the inpatient setting. Objective To determine whether …

OBJECTIVE: To systematically review evidence relating to the clinical efficacy of oseltamivir,
zanamivir and amantadine in the prevention of influenza. METHODS: RCTs evaluating …

Background: Neuraminidase inhibitors (NAIs) are stockpiled internationally for extended use
in an influenza pandemic. Purpose: To evaluate the safety and efficacy of extended-duration …